We previously showed that this is mainly driven by IFNB1, whose transcript is detectable in muscle of >60% of DM patients and whose protein product (IFN-β) drives the expression of itself and IFN-I-inducible genes in cultured human myoblasts[18]. Here, IFNB1 is linked to dermatomyositis.